Tokyo, Japan, May 13, 2013 – Astellas Pharma Inc. (Tokyo: 4503; President and CEO: Yoshihiko Hatanaka, hereinafter called “the Company”) announced that at the meeting of the Board of Directors held today, a resolution was adopted that the Company will cancel its treasury stock, pursuant to Article 178 of the Japanese Corporate Law.


1.    Class of shares to be cancelled : Common stock of the Company
2.    Number of shares to be cancelled:  11 million shares      (Representing 2.4% of issued shares prior to cancellation)
3.    Cancellation date: May 31, 2013


Following cancellation, the Company will have 456,964,635 issued shares.
Total number of the Company’s treasury stock after cancellation will be 5,788,579.
(Expected numbers of shares described above 1 and 2 were calculated on the basis of the issued shares and the Company’s treasury stock as of March 31, 2013, respectively.)



Contact the Media Relations team
Communications & Investor Relations
Main phone line for Media: +81-3244-3201 
Business hours (JST)
From Monday to Thursday: 8:45 am to 5:45 pm, Friday: 8:45 am to 4:00 pm
(closed on Saturdays, Sundays, national holidays and company holidays)